Oncology & Immunology

Expert reports about Oncology & Immunology


THE SAFETY OF IMATINIB (GLEEVEC) DURING PREGNANCY OR BREASTFEEDING

 

THIS MEDICATION CAN CAUSE HARM TO YOUR BABY:

Despite limited human data, there is a potential risk of adverse effects on the developing baby with exposure during pregnancy. It is recommended to avoid this medication during pregnancy and breastfeeding unless the benefit to the mother outweighs the risk to the baby.


TO READ THE FULL REPORT

Join Pregistry to access the information you need at no cost to you

Join Pregistry